Exeter Patients May Have Suffered Pain from Drug Diversion
If convicted, Kwiatkowski faces up to 10 years in prison for each count of tampering with a consumer product and up to four years in prison for each count of obtaining controlled substances by fraud, with each offense punishable with a fine of $250,000 and a term of supervised release following imprisonment.
Exeter Hospital has failed three state/federal inspection surveys stemming from the episode, which was discovered in May when numerous patients showed up with unexplained acute infections with hepatitis C. According to the latest inspection report released Wednesday, numerous infection control issues remain.
If not corrected by the time state and federal officials conduct a follow-up inspection, Exeter could lose its ability to receive reimbursement for Medicare and Medicaid patients, which would be a significant loss of revenue.
According to the U.S. Attorney's Office indictment, Kwiatkowski was employed as a healthcare worker in Michigan, and in 2007 became a "traveling healthcare technician, employed in various states including New York, Pennsylvania, Maryland, Arizona, Kansas, Georgia, and New Hampshire."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Tips for Managing Employed Physicians
- House Calls Key to Pioneer ACO Success
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers